Pancreatology

Pancreatology

胰腺学

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Pancreatology》是由Elsevier BV出版社于2001年创办的英文国际期刊(ISSN: 1424-3903,E-ISSN: 1424-3911),该期刊长期致力于胃肠肝病学领域的创新研究,主要研究方向为医学-胃肠肝病学。作为SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0839...%),以发表胃肠肝病学领域等方向的原创性研究为核心(研究类文章占比95.35%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在129篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Pancreatology审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约129篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 129 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q2 62 / 143

57%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q2 49 / 143

66.08%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.2 SJR:1.246 SNIP:1.094
学科类别 分区 排名 百分位
大类:Medicine 小类:Endocrinology, Diabetes and Metabolism Q2 62 / 244

74%

大类:Medicine 小类:Hepatology Q2 24 / 82

71%

大类:Medicine 小类:Endocrinology Q2 42 / 128

67%

期刊发文

  • A single-center experience on endoscopic ultrasonography-guided ethanol ablation of insulinomas

    Author: Yan, Zhiyu; Zhu, Cheng; Wu, Xi; Zhu, Huijuan; Yuan, Tao; Luo, Yaping; Feng, Yunlu; Wang, Qiang; Zhang, Shengyu; Xue, Huadan; Zheng, Zehui; Yang, Aiming

    Journal: PANCREATOLOGY. 2023; Vol. 23, Issue 1, pp. 98-104. DOI: 10.1016/j.pan.2022.12.007

  • Optimising the measurement of intra-bladder pressure in patients with predicted severe acute pancreatitis

    Author: Li, Linqian; Zhang, Xiaoying; Cheng, Guilan; Wang, Dingxi; Liu, Shiyu; Li, Lan; Shi, Na; Jin, Tao; Lin, Ziqi; Deng, Lihui; Huang, Wei; Windsor, John A.; Li, Guixiang; Xia, Qing

    Journal: PANCREATOLOGY. 2023; Vol. 23, Issue 1, pp. 18-27. DOI: 10.1016/j.pan.2022.11.007

  • Presumed radiological diagnosis of solid pseudopapillary tumors: do we really know what we are watching?

    Author: He, Chengqing; Zhu, Liang; Wang, Xuan; Dai, Menghua; Wu, Huanwen; Xu, Qiang; Sun, Zhaoyong; Liu, Jingyi; Xue, Huadan; Jin, Zhengyu

    Journal: PANCREATOLOGY. 2023; Vol. 23, Issue 1, pp. 120-128. DOI: 10.1016/j.pan.2022.12.006

  • Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms

    Author: Gao, Changhao; Fan, Zhiyao; Yang, Jian; Shi, Ming; Li, Yongzheng; Zhan, Hanxiang

    Journal: PANCREATOLOGY. 2023; Vol. 23, Issue 2, pp. 204-212. DOI: 10.1016/j.pan.2023.01.009

  • Should a standard lymphadenectomy include the No. 9 lymph nodes for body and tail pancreatic ductal adenocarcinoma?

    Author: Yiran Zhou, Jiewei Lin, Wei Wang, Hao Chen, Xiaxing Deng, Chenghong Peng, Dongfeng Cheng, Baiyong Shen

    Journal: PANCREATOLOGY, 2019, Vol., , DOI:10.1016/j.pan.2019.03.005

  • Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis

    Author: Heli Gao, Wenquan Wang, Huaxiang Xu, Chuntao Wu, Wei Jin, Shirong Zhang, Jinzhi Xu, Quanxing Ni, Xianjun Yu, Liang Liu

    Journal: PANCREATOLOGY, 2019, Vol., , DOI:10.1016/j.pan.2019.02.011

  • The product value of serum albumin and prothrombin time activity could be a useful biomarker for severity prediction in AP: An ordinal retrospective study

    Author: Shoukang Li, Zhiqiang Liu, Heshui Wu

    Journal: PANCREATOLOGY, 2019, Vol.19, 230-236, DOI:10.1016/j.pan.2019.02.001

  • CA19-9 elevation as an indication to start salvage treatment in surveillance after pancreatic cancer resection

    Author: Jiarui Li, Zhe Li, Haoxuan Kan, Zhao Sun, Jiazhang Xing, Yuejuan Cheng, Chunmei Bai

    Journal: PANCREATOLOGY, 2019, Vol.19, 302-306, DOI:10.1016/j.pan.2019.01.023